The current valuation score of INmune Bio Inc is 6.40, ranking 336 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.88, which is -38.81% below the recent high of -0.54 and -854.39% above the recent low of -8.39.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.